Molecular Subtypes as Predictive Biomarkers of Response and Outcomes After Neoadjuvant Chemotherapy in Patients With Bladder Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Basal/squamous and Mixed subtype bladder cancers present poor outcomes after neoadjuvant chemotherapy in the VESPER trial
Ann. Oncol 2024 Sep 17;[EPub Ahead of Print], CS Groeneveld, C Pfister, S Culine, V Harter, C Krucker, J Fontugne, V Dixon, N Sirab, I Bernard-Pierrot, A de Reyniès, F Radvanyi, Y AlloryFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.